Clinical Usefulness of Aripiprazole Treatment in a Girl with Prader-Willi Syndrome and Psychosis
Clinical Psychopharmacology and Neuroscience
;
: 497-500, 2018.
Article
in English
| WPRIM
| ID: wpr-718210
ABSTRACT
Prader-Willi syndrome (PWS) is a quite rare multi-systemic genetic disorder strongly associated with psychiatric illness in adults, especially psychosis. This report presents a 16-year-old female with PWS and symptoms of brief psychotic disorder with a complete resolution of symptoms under aripiprazole medication. However, an exacerbation occurred after aripiprazole reduction. Apart from a weight gain of about 2 kg over the course of two years, no adverse effects could be found. This first report on the use of aripiprazole in a subject with PWS and psychosis suggests that aripiprazole might be a promising treatment approach in this distinct group of patients.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Prader-Willi Syndrome
/
Psychotic Disorders
/
Weight Gain
/
Aripiprazole
Limits:
Adolescent
/
Adult
/
Female
/
Humans
Language:
English
Journal:
Clinical Psychopharmacology and Neuroscience
Year:
2018
Type:
Article
Similar
MEDLINE
...
LILACS
LIS